血管生成素样蛋白6(ANGPTL6)重组蛋白
Recombinant Angiopoietin Like Protein 6 (ANGPTL6)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
|
Organism species
|
Homo sapiens (Human)
|
|
Product No.
|
KL468Hu01
|
|
Source
|
Prokaryotic expression
|
|
Host
|
E.coli
|
|
Purity
|
> 95%
|
|
UOM
|
50ug
|
|
Predicted Molecular Mass
|
28.4kDa
|
|
Concentration
|
n/a
|
|
Applications
|
SDS-PAGE; WB; ELISA; IP.
|
|
Endotoxin Level
|
<1.0EU per 1µg (determined by the LAL method)
|
|
Residues
|
Trp257~Leu470 with two N-terminal Tags, His-tag and T7-tag
|
|
Formulation
|
Supplied as lyophilized form in PBS, pH7.4, containing 5% trehalose, 0.01% sarcosyl.
|
血管生成素样蛋白6(ANGPTL6)重组蛋白SEQUENCES
The sequence of the target protein is listed below.
WQDC AEARQAGHEQ SGVYELRVGR HVVSVWCEQQ LEGGGWTVIQ RRQDGSVNFF TTWQHYKAGF GRPDGEYWLG LEPVYQLTSR GDHELLVLLE DWGGRGARAH YDGFSLEPES DHYRLRLGQY HGDAGDSLSW HNDKPFSTVD RDRDSYSGNC ALYQRGGWWY HACAHSNLNG VWHHGGHYRS RYQDGVYWAE FRGGAYSLRK AAMLIRPLKL
血管生成素样蛋白6(ANGPTL6)重组蛋白USAGE
Reconstitute in sterile ddH2O.
血管生成素样蛋白6(ANGPTL6)重组蛋白STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
血管生成素样蛋白6(ANGPTL6)重组蛋白About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL135Hu01 血小板生成素(TPO)重组蛋白 Recombinant Thrombopoietin (TPO) Homo sapiens (Human)
KL135Mu01 血小板生成素(TPO)重组蛋白 Recombinant Thrombopoietin (TPO) Mus musculus (Mouse)
KL135Po01 血小板生成素(TPO)重组蛋白 Recombinant Thrombopoietin (TPO) Sus scrofa; Porcine (Pig)
KL135Ra01 血小板生成素(TPO)重组蛋白 Recombinant Thrombopoietin (TPO) Rattus norvegicus (Rat)
KL139Ca01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)重组蛋白 Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) Canis familiaris; Canine (Dog)
KL139Hu01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)重组蛋白 Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) Homo sapiens (Human)
KL139Mu01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)重组蛋白 Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) Mus musculus (Mouse)
KL139Ra01 肿瘤坏死因子相关凋亡诱导配体(TRAIL)重组蛋白 Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) Rattus norvegicus (Rat)
KL140Bo01 尿激酶型纤溶酶原激活因子(uPA)重组蛋白 Recombinant Plasminogen Activator, Urokinase (uPA) Bos taurus; Bovine (Cattle)
KL140Ga01 尿激酶型纤溶酶原激活因子(uPA)重组蛋白 Recombinant Plasminogen Activator, Urokinase (uPA) Chicken (Gallus)
KL140Hu01 尿激酶型纤溶酶原激活因子(uPA)重组蛋白 Recombinant Plasminogen Activator, Urokinase (uPA) Homo sapiens (Human)
